Sunjin Beauty Science
At a glance
Sunjin Beauty Science filed 38 disclosures in the last 12 months, including 7 insider, 3 5% holder, 2 m&a and 1 buyback. The most recent key filing was on Oct 16: Auditor bought 4,721 sh on the market at an average ₩6,706, Oct 15.
Revenue for 2025 was ₩80.8B, up 1.8% on 2024. Operating margin was 7.5% against 13.4% a year earlier. Debt was 95% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩46.3B and operating profit of ₩3.2B.
The 2025 annual report lists 228 employees with an average tenure of 3 years and average pay of ₩49.2M, #1483 of 1,829 listed companies by average pay. Its 4 directors and auditors were paid ₩137.4M each on average. It paid ₩200 per common share in cash dividends, against ₩60 a year earlier (+233.3%). 이성호 and related parties held 54.64% at year end.
From the 2025 annual report
Staff: 228 (128 men, 100 women), of whom 32 on fixed-term contracts. Total pay for the year: ₩11.2B. Directors and auditors: 4, paid ₩549.5M in total.
Dividends (common shares)
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash dividend per share | ₩200 | ₩60 | ₩40 |
| Payout ratio | 40.3% | 6.9% | 7.2% |
| Yield (as filed) | 2.15% | 0.65% | 0.40% |
| Total cash dividends | ₩2.4B | ₩721M | ₩480M |
Largest shareholder
이성호 holds 42.36%; with 11 related parties the group holds 54.64% of common shares at year end.
Auditor: 동현회계법인 · opinion: Unqualified.
Rankings: Dividend growth #20 of 917
Source: 2025 annual business report (DART). How figures are combined
Financial summary
Key filings
Other filings
Links open the original filing on DART, in Korean.